Skip to main content

US Physical Therapy Value Stock - Dividend - Research Selection

Us physical therapy

ISIN: US90337L1089 , WKN: 923954

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It provides workforce performance solutions, including onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments for Fortune 500 companies, and other clients comprising insurers and their contractors. As of March 13, 2018, it operated 579 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)

2026-05-22
U.S. Physical Therapy has seen valuation multiples compress significantly despite continued revenue growth. Learn why USPH stock is upgraded to a hold.

3 Reasons USPH is Risky and 1 Stock to Buy Instead

2026-05-21
U.S. Physical Therapy currently trades at $65.04 per share and has shown little upside over the past six months, posting a small loss of 4.3%. The stock also fell short of the S&P 500’s 11.6% gain during that period.

Do These 3 Checks Before Buying U.S. Physical Therapy, Inc. (NYSE:USPH) For Its Upcoming Dividend

2026-05-18
Readers hoping to buy U.S. Physical Therapy, Inc. ( NYSE:USPH ) for its dividend will need to make their move shortly...

Stocks making big moves yesterday: Helios, DraftKings, CACI, U.S. Physical Therapy, and Ulta

2026-05-17
Check out the companies making headlines yesterday:

U.S. Physical Therapy’s Q1 Earnings Call: Our Top 5 Analyst Questions

2026-05-17
U.S. Physical Therapy’s first quarter results were met with a sharp negative market reaction, reflecting investor concerns over margin compression and profit performance. Management attributed the quarter's margin decline primarily to severe winter weather, which led to over 31,000 lost patient visits and higher fixed costs, as well as upfront investments in new initiatives. CEO Christopher J. Reading acknowledged that, despite robust demand and higher commercial reimbursement rates, these headw

U.S. Physical Therapy (USPH) Stock Is Up, What You Need To Know

2026-05-16
Shares of outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) jumped 4.4% in the afternoon session after the stock continued to rally as the company reported solid first-quarter 2026 results, highlighted by strong revenue growth and a confirmation of its full-year financial outlook.

U.S. Physical Therapy Presented at the BofA Securities 2026 Healthcare Conference

2026-05-14
HOUSTON, May 14, 2026--U.S. Physical Therapy, Inc. (the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, Chairman and Chief Executive Officer, presented at the BofA Securities 2026 Healthcare Conference held on May 13, 2026. The presentation included a discussion of the overall operating environment in healthcare, the Company's key initiatives and a broad over

Barrington Research Maintains Outperform on US Physical Therapy, Lowers Price Target to $90

2026-05-13
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and lowers the price target from $103 to $90.

U.S. Physical Therapy, Inc. 2026 Q1 - Results - Earnings Call Presentation

2026-05-12
2026-05-12. The following slide deck was published by U.S.

U.S. Physical Therapy, Inc. (USPH) Q1 2026 Earnings Call Transcript

2026-05-08
U.S. Physical Therapy, Inc.